US 12,133,969 B2
Translating therapy parameters of an insulin therapy system to translated therapy parameters for use at a different insulin therapy system
Benyamin Grosman, West Hills, CA (US); and Yuxiang Zhong, Arcadia, CA (US)
Assigned to MEDTRONIC MINIMED, INC., Northridge (CA)
Filed by MEDTRONIC MINIMED, INC., Northridge, CA (US)
Filed on Dec. 10, 2020, as Appl. No. 17/118,519.
Claims priority of provisional application 62/947,988, filed on Dec. 13, 2019.
Prior Publication US 2021/0178067 A1, Jun. 17, 2021
Int. Cl. A61M 5/172 (2006.01); G06F 3/01 (2006.01); G16H 20/17 (2018.01); G16H 40/40 (2018.01); A61M 5/14 (2006.01); A61M 5/142 (2006.01)
CPC A61M 5/1723 (2013.01) [G06F 3/017 (2013.01); G16H 20/17 (2018.01); G16H 40/40 (2018.01); A61M 2005/1401 (2013.01); A61M 2005/14288 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/35 (2013.01); A61M 2230/201 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A method performed by a translation service hosted at a server system for translating one or more therapy parameters of a first insulin therapy system to one or more translated therapy parameters for use at a second insulin therapy system, the method comprising:
sending a therapy profile generated at the first insulin therapy system to a translation service, the therapy profile comprising one or more therapy parameters;
translating at least one therapy parameter from the therapy profile into at least one translated therapy parameter that is mapped to and adapted for use by the second insulin therapy system that is different than the first insulin therapy system; and
sending the at least one translated therapy parameter to the second insulin therapy system for use at the second insulin therapy system;
wherein:
each of the first insulin therapy system and the second insulin therapy system comprises one of a continuous insulin therapy system or a discrete insulin therapy system, the first and second insulin therapy systems comprising the continuous insulin therapy system and the discrete insulin therapy system;
the continuous insulin therapy system comprises an insulin infusion device that regulates delivery of insulin to a user, and a glucose sensor to provide sensor data that indicates a glucose level of the user; and
the discrete insulin therapy system comprises an insulin injection device that is used to discretely inject insulin.